Christoph U. Correll, MD

Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Department of Child and Adolescent Psychiatry, Charité–Universitätsmedizin Berlin, Berlin, Germany; German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany; Corresponding Author: Christoph U. Correll, MD, Psychiatry Research, The Zucker Hillside Hospital, 75-59 263rd St, Glen Oaks, NY 11004 ([email protected]).

JCP
Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia
Review Article

August 21, 2024

Patients with schizophrenia and cognitive impairment had a 100% increase in relapse-related hospitalizations and ER visits versus patients with no (or only mild) cognitive impairment.
Christoph U. Correll, Pin Xiang, Kaushik Sarikonda, et al
PCC
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
Narrative Review

January 30, 2024

While oral and intramuscular formulations of pharmacologic agents continue to be commonly used to treat acute agitation, novel agents with alternative routes of delivery are becoming available.
Leslie Citrome, Christoph U. Correll, Luis San, et al
JCP
The Clinician’s Tardive Inventory
Original Research

January 24, 2024

Accurately identifying the severity and functional impact of tardive dyskinesia is essential. This report describes a new instrument, the Clinician’s Tardive Inventory, which aims to address shortcomings of existing...
Richard M. Trosch, Cynthia L. Comella, Stanley N. Caroff, et al
JCP
Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use
Letter to the Editor

January 22, 2024

The authors provide additional relative risk data in response to Dr Andrade’s comments on their study.
Heidi Taipale, Marco Solmi, Christoph U. Correll, et al
JCP
Outcome Predictors in Youth With Mental Disorders
Original Research

December 27, 2023

This retrospective analysis of clinical parameters in youth hospitalized for psychiatric treatment assessed magnitude and correlates of symptom response, global illness response, social functioning, out-of-home placement, and length of...
Viktor B. Nöhles, Charlotte Jaite, Kerstin Rubarth, et al
JCP
Olanzapine/Samidorphan Mitigates Weight Gain in Early Illness
Original Research

March 22, 2023

In patients with early-phase schizophrenia or bipolar disorder, combination olanzapine and samidorphan resulted in less weight gain at week 12 than olanzapine alone. Antipsychotic efficacy was similar between the...
René S. Kahn, John M. Kane, Christoph U. Correll, et al
PCC
State of the Art of Diagnostics and Genetics in Huntington’s Chorea
Letter to the Editor

March 7, 2023

Mayank Gupta, MD, and Christoph U. Correll, MD, respond to Herwig Lange, MD, regarding their previous case report of a patient with Huntington’s disease.
Mayank Gupta, Christoph U. Correll
JCP
Patient Functioning and Life Engagement: Treatment Goals in MDD
Insight videos

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...
Christoph U. Correll, Zahinoor Ismail, Roger S. McIntyre, et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder
Academic Highlights

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...
Christoph U. Correll, Zahinoor Ismail, Roger S. McIntyre, et al
JCP
Reasons for Switching Antipsychotic Treatments
Original Research

September 5, 2022

Based on prescription records and prescriber notes, almost half of antipsychotic switches were due to side effects, and women were especially likely to be switched due to intolerability or...
Daniel Guinart, Kaksha Varma, Yarden Segal, et al
JCP
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
Insight videos

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...
Christoph U. Correll, Zahinoor Ismail, Roger S. McIntyre, et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
Academic Highlights

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...
Christoph U. Correll, Zahinoor Ismail, Roger S. McIntyre, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe